HAGP1MAG-12K
MILLIPLEX® 人血管生成/生长因子磁珠板 - 癌症多重检测
Angiogenesie Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous analysis of multiple angiogenic biomarkers in human serum, plasma and cell culture samples.
别名:
human oncology growth factor immunoassay panel, luminex human cancer angiogenesis growth factor multiplex assay, millipore human cancer growth factor protein multiplex kit
About This Item
推荐产品
品質等級
物種活性
human
製造商/商標名
Milliplex®
assay range
accuracy: 42-131%
standard curve range: 1.4-1,000 pg/mL
(HB-EGF, IL-8, PLGF)
standard curve range: 13.7-10,000 pg/mL
(Angiopoietin-2, FGF-1, FGF-2, G-CSF, VEGF-A)
standard curve range: 137.2-100,000 pg/mL
(Leptin)
standard curve range: 2.7-2,000 pg/mL
(BMP-9, EGF, Endothelin-1)
standard curve range: 27.4-20,000 pg/mL
(Endoglin, Follistatin, HGF)
standard curve range: 6.9-5,000 pg/mL
(VEGF-C, VEGF-D)
技術
multiplexing: suitable
檢測方法
fluorometric (Luminex xMAP)
運輸包裝
wet ice
一般說明
MILLIPLEX®人血管生成/生长因子面板1用于同时定量人血浆、血清样品和组织/细胞裂解物和因子上清液样品中以下17种人血管生成和生长培养生物标志物的任何或全部:血管生成素-2、BMP-9、EGF、内皮糖蛋白、内皮素-1、FGF-1(酸性FGF)、FGF-2(碱性FGF)、卵泡抑素、G-CSF、HB-EGF、HGF、IL-8、瘦素、PLGF、VEGF-A、VEGF-C和VEGF-D。该试剂盒采用96孔板,包含冻干标准混合物、两个内部检测质控品,最多可测量38份样品,一式两份。
Luminex® xMAP®平台使用磁珠免疫分析格式,以实现理想的速度和灵敏度,同时定量多种分析物,从而显著提高生产力,同时节省宝贵的样本量。
面板类型:循环癌症
特異性
抗体与该面板中任何其他分析物之间的交叉反应性都为无法检测或可忽略。
應用
- 分析物:血管生成素-2、BMP-9、EGF、内皮糖蛋白、内皮素-1、FGF-1(酸性FGF)、FGF-2(碱性FGF)、卵泡抑素、G-CSF、HB-EGF、HGF、IL-8、瘦素、PLGF、VEGF-A、VEGF-C、VEGF-D
- 推荐的样品类型:人血清、血浆、组织/细胞裂解物或培养上清液
- 推荐的样品稀释度:每孔25 μL血浆或血清的1:3稀释液;每孔25 μL细胞培养上清液,根据需要用适当的对照培养基稀释
- 分析运行时间:在2-8℃下过夜(16-18小时)
- 研究类别:癌症
特點和優勢
包裝
儲存和穩定性
其他說明
法律資訊
免責聲明
訊號詞
Danger
危險分類
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
標靶器官
Respiratory Tract
儲存類別代碼
10 - Combustible liquids
相关内容
The angiogenesis pathway is complex with many targets to analyze. Simultaneous quantification of multiple markers, with the MILLIPLEX® Human Angiogenesis/Growth Factor Panel 1, saves valuable resources. See how this panel was used to correlate angiogenesis biomarkers with early metastatic progression in NSCLC.
Detection of cancer biomarkers through multiplex cancer assays can accelerate studies of normal homeostasis and tumorigenic processes. See how MILLIPLEX® multiplex cancer assays are advancing various cancer research areas including lung cancer, breast cancer, and immuno-oncology research.
See how MILLIPLEX® multiplex immunoassays offer researchers the ability to simultaneously quantitate a large number of human cytokines, chemokines, and growth factors, and detect human immunoglobulins against SARS-CoV-2 antigens, to better understand the immune response to COVID-19, including cytokine storm.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持